Delivery Order SPE2DB24D9131-SPE2DB24FXRN2

Award Date 7/10/24
Potential Completion Date 7/31/24
Potential Value $7.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $42,881.40, is for the supply of NEXPLANON 68 MG IMPLANTS to support the medical supply needs of military health facilities. This award is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999,...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $7,146.90 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of Nexplanon 68 mg implants. This order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which allows the agency to issue delivery orders for a wide range of...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The $7,146.90 contract is for the supply of NEXPLANON 68 MG IMPLANTS to support the recurring medical needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,429.38 firm fixed-price contract is for the delivery of NEXPLANON 68 MG IMPLANTS, with a period of performance through May 2, 2024. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract, contract 4600082013 under the SPE2DB program, valued at up to $4,999,999 through the end of 2025. Through...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,288.14 firm fixed-price contract is for the delivery of 4,564,449,404 NEXPLANON 68 MG IMPLANTS. This order is part of a larger single-award indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA, valued up to $499,999,999, which runs through December 31, 2025. The IDC...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $82,048.80, is for the delivery of 4562244975 NEXPLANON 68 MG IMPLANTS to support the medical supply needs of military health facilities. This delivery order contract is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,144.07, is for the delivery of 68 mg Nexplanon implants. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, which runs through December 31, 2025. The IDC allows the DLA to issue firm fixed-price...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $4,288.14, is for the delivery of NEXPLANON 68 MG IMPLANTS to support the medical supply needs of military health facilities. This award is under a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued up to $499,999,999, which runs through December 31, 2025. The IDC...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $7,146.90 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of NEXPLANON 68 MG IMPLANTS and has an ultimate completion date of July 12, 2024. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $6,837.40, is for the delivery of 4,562,331,276 Nexplanon 68 mg implants. This delivery order is issued under a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, which allows the DLA to order a comprehensive...
  • SPE2DB24D9131
    Indefinite Delivery Contract
  • SPE2DB24D9131-SPE2DB24FXRN2
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $7,146.90, is for the delivery of NEXPLANON 68 MG IMPLANTS to fulfill the recurring medical supply needs of military health facilities.

This delivery order is part of a larger single-award indefinite delivery contract (IDC) vehicle under the DLA's SPE2DB program, valued at up to $499,999,999 and running through December 31, 2025. Through this IDC, DMS Pharmaceutical Group provides a wide range of pharmaceutical products, including both common and specialized medications, to support the diverse medical requirements of Department of Defense (DoD) healthcare facilities and personnel worldwide. The contract does not have a set-aside designation.

Generated 10/9/24, 9:08 AM